Crusader - Agent is correct. EMvision has never deviated from the de Novo pathway since receiving guidance from FDA in early 2021 and announcing it (FDA Provides De Novo Guidance) on 25 Jan 2021.
Similarly EMV has always articulated the 510k pathway for Gen 2, because of the predicate device in the form of the Gen 1 EMU.
EMV Price at posting:
$1.99 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)